(Last updated : 2020-09-24 16:06:21)
  富山 恭行
   Department     ,
   Position  
■ Journal
1. 2019/01 Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.  Link
2. 2018/06 Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts the development of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.  Link
3. 2018/06 Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts the development of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. 
4. 2016/08 Assessment of hepatic fibrosis with superb microvascular imaging in hepatitis C virus-associated chronic liver diseases 
5. 2015/10 Multicenter comparative study of laparoscopic and open distal pancreatectomy using propensity score-matching 
Display all(19)
■ Presentation
1. 2017/10/23 Dipeptidyl peptidase 4 inhibitors reduce hepatocellular carcinoma by activating natural killer cell chemotaxis in mice  
2. 2017/10/21 Development of hepatocellular carcinoma after treatment with direct acting antivirals in hepatitis C virus-associated chronic liver diseases  
3. 2016/09/22 Comparison of therapeutic effect of sorafenib and drug eluting beads transcatheter arterial chemoembolization on hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization  
4. 2016/02/22 DPP-4 inhibitor, anagliptin suppresses the progression of Hepatocellular carcinoma  
5. 2015/11/16 CD26 (DPP-4) as a molecular target for HCC treatment  
Display all(48)